CALL FOR NOMINATIONS: NAS and NAM Initiative on Human Gene Editing
By Announcement,
Committee On Science, Technology, and Law
| 06. 24. 2015
Untitled Document
The National Academy of Sciences and the National Academy of Medicine are launching a major initiative to guide decision making about controversial new research involving human gene editing. Human gene-editing technologies, such as CRISPR-Cas9, may lead to promising new treatments for disease. However, recent experiments to attempt to edit human genes also have raised important questions about the potential risks and ethical concerns of altering the human germline.
Our initiative will include an international summit in late 2015 to convene researchers and other experts to explore the scientific, ethical, legal, and policy issues associated with human gene-editing research. In addition, we will appoint a multidisciplinary, international committee to begin a comprehensive study of the scientific underpinnings and clinical, ethical, legal, and social implications of human gene editing. The committee will consider and recommend standards, guidelines, and practices governing the use of gene-editing technologies in biomedical research and medicine.
We are seeking nominations for both the planning committee for the international summit and the consensus study committee. We invite suggestions for scientists with expertise in molecular and developmental biology...
Related Articles
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Charlie Warzel and Hana Kiros, The Atlantic | 06.24.2025
Image "Elon Musk" by Debbie Rowe on Wikimedia Commons licensed under CC by S.A. 3.0
In April, Ezibon Khamis was dispatched to Akobo, South Sudan, to document the horrors as humanitarian services collapsed in the middle of a cholera outbreak. As...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...